Skip to main content
. 2020 Apr 29;7(5):ofaa152. doi: 10.1093/ofid/ofaa152

Table 1.

Demographic and Clinical Features in 14 Fatal Cases of SARS-CoV-2 Pneumonia

Patient Age, y Sex Medical History CT Nuclear Acid Test Maximal Temperature, ºC Glucocorticoid Therapy Complication Duration of Clinical Course, d
1 54 M Hypertension Bilateral, 2nd week confirmed, 3rd week alleviated Positive 39.3 Yes Cardiac and respiratory arrest 28
2 78 M Diabetes Positive (outside hospital) Positive 39.1 Yes Cardiac and respiratory arrest 10
3 88 M Encephalotrophy, smoking Bilateral positive Positive 39 Yes Acute respiratory distress syndrome 9
4 84 F Hypertension and diabetes Bilateral positive Positive 39 Yes Heart and respiratory failure, severe pneumonia 6
5 78 M Hypertension and heart failure Bilateral positive Positive 38.7 Yes Cardiac and respiratory arrest 5
6 67 F Chronic bronchitis, hypertension, GI ulceration, liver cirrhosis, esophagus carcinoma Right side positive Positive 38.3 Yes Respiratory failure 28
7 72 M Chronic bronchitis Bilateral positive Positive 39.4 Yes Heart failure 13
8 92 M Brain infarction Bilateral positive NA 38.5 Yes Acute respiratory distress syndrome 20
9 36 M Unknown Bilateral positive NA 39.5 Yes Acute respiratory distress syndrome, septic shock 14
10 81 M Cardiac disease Bilateral positive NA 38.9 Yes Septic shock 7
11 66 M Chronic renal failure, hypertension Bilateral positive Positive 36.6 NA Cardiac and respiratory arrest 8
12 70 M Unknown Bilateral positive NA 39 Yes Cardiac and respiratory arrest 18
13 38 M Lymphoma Right lung positive Positive 39.8 NA GI bleeding 19
14 84 F Lung cancer, hypertension, diabetes Bilateral positive Positive Normal NA Multiple organ failure 28

Abbreviations: CT, computed tomography; d, day; GI, gastrointestinal; NA, not applicable; y, year.